| 4969 |
Centers for Disease Control and Prevention |
Html |
en |
Barriers to colorectal cancer screening: physician and general population perspectives, New Mexico, 2006 |
null |
| CRC testing | 0.487735 |
| electronic medical records | 0.483249 |
| New Mexico BRFSS | 0.501863 |
| upper age limit | 0.502456 |
| primary care providers | 0.588708 |
| CRC screening decision | 0.587979 |
| New Mexico VA | 0.49121 |
| physician respondents | 0.519209 |
| barium enema | 0.500531 |
| CRC screening | 0.894644 |
| Prevention Initiative CRC | 0.496478 |
| Clinical Prevention Initiative | 0.511819 |
| patients | 0.55038 |
| Cancer Screening Practices | 0.560214 |
| markedly different perspectives | 0.48288 |
| CRC incidence | 0.499643 |
| primary care physicians | 0.635761 |
| new CRC cases | 0.525478 |
| respondents | 0.584176 |
| BRFSS respondents | 0.492092 |
| New Mexico Cancer | 0.491576 |
| fecal occult blood | 0.485411 |
| average-risk patients | 0.51859 |
| cancer screening beliefs | 0.56773 |
|
| screening barriers | 0.578602 |
| cancer screening | 0.585632 |
| screening tests | 0.526552 |
| home FOBT | 0.492296 |
| lower endoscopy | 0.548546 |
| general population | 0.505856 |
| flexible sigmoidoscopy | 0.525799 |
| screening practices | 0.668128 |
| CRC screening practices | 0.65687 |
| state-specific CRC screening | 0.632645 |
| effective screening | 0.549411 |
| colonoscopy | 0.483917 |
| health care | 0.483544 |
| New Mexico School | 0.492657 |
| health | 0.485736 |
| barriers | 0.602525 |
| New Mexico | 0.984575 |
| screening procedures | 0.533417 |
| primary care | 0.72679 |
| low screening proportions | 0.573358 |
| screening rates | 0.55476 |
| physician survey | 0.516656 |
| higher screening rates | 0.538624 |
| New Mexico Department | 0.611365 |
|
CLICK HERE |
| 5830 |
Centers for Disease Control and Prevention |
Html |
en |
2,4-Diaminoanisole (and its salts) - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 6269 |
Centers for Disease Control and Prevention |
Html |
en |
Information for Educators - FASD |
FASDs are 100% preventable if a woman does not drink alcohol during pregnancy. There is no known safe amount of alcohol to drink while pregnant. There is also no safe time during pregnancy to drink and no safe kind of alcohol. |
| Maternal Substance Abuse | 0.233973 |
| effective parenting techniques | 0.223648 |
| Science Ambassador Program | 0.227293 |
| child development | 0.328038 |
| Tribal Justice Systems | 0.222781 |
| Substance Abuse | 0.249018 |
| Provider Resource Kit | 0.372145 |
| Childcare Provider Resource | 0.3819 |
| middle school children | 0.459826 |
| related conditions | 0.244065 |
| K-12 FASD Education | 0.306535 |
| various child development | 0.2254 |
| fetal alcohol | 0.91109 |
|
| FASDs | 0.252508 |
| Fetal Alcohol Syndrome | 0.775828 |
| Double ARC | 0.342026 |
| separate training curricula | 0.222972 |
| Healthy Path curriculum | 0.233521 |
| high school students | 0.222905 |
| alcohol spectrum disorders | 0.715229 |
| FASD Toolbox | 0.208725 |
| Mental Health Services | 0.231535 |
| Alcohol Syndrome Awareness | 0.28583 |
| Child Development Center | 0.244887 |
| fetal alcohol spectrum | 0.764746 |
| future science teachers | 0.241539 |
|
CLICK HERE |
| 7327 |
Centers for Disease Control and Prevention |
Html |
en |
Muscular Dystrophy - Duchenne/Becker Muscular Dystrophy (DBMD) - Data and Statistics |
null |
| Becker muscular dystrophy | 0.804168 |
| Romitti PA | 0.243084 |
| United States | 0.202496 |
| DBMD | 0.292806 |
| DBMD ages | 0.270801 |
| Meaney FJ | 0.200646 |
| Fox DJ | 0.330828 |
| oldest males | 0.267511 |
| muscular dystrophy | 0.964714 |
| Duchenne muscular dystrophy | 0.665046 |
| non-hispanic black males | 0.426479 |
| DMD | 0.270966 |
| average age | 0.214067 |
| probable Duchenne | 0.241329 |
| MD STARnet sites | 0.337418 |
|
| Research Network | 0.229992 |
| genetic testing results | 0.255654 |
| MD STARnet | 0.670861 |
| Non-Hispanic blacks | 0.219054 |
| Non-Hispanic whites | 0.217904 |
| males | 0.584118 |
| Muscular Dystrophy Surveillance | 0.419564 |
| Becker muscular dystrophies | 0.265398 |
| steroid treatment | 0.233162 |
| non-Hispanic white males | 0.426107 |
| medical record | 0.232341 |
| MD STARnet case | 0.239651 |
| non-Hispanic white children | 0.254617 |
| Duchenne/Becker muscular dystrophy | 0.304647 |
|
CLICK HERE |
| 7829 |
Centers for Disease Control and Prevention |
Html |
en |
Pregnancy Complications and Death - Health Communication |
Gateway to Health Communication and Social Marketing Practice - Pregnancy Complications and Death |
| pregnancy-related causes | 0.416842 |
| good care | 0.246012 |
| direct result | 0.311489 |
| excessive bleeding | 0.299796 |
| experience complications | 0.285131 |
| regular check-ups | 0.279801 |
| unintended pregnancies | 0.314378 |
| appropriate management | 0.257356 |
| unrelated condition | 0.323531 |
| socioeconomic background | 0.288077 |
| 36-year-old woman | 0.276973 |
| pregnancy complications | 0.32224 |
| major causes | 0.280218 |
| pulmonary embolism | 0.327532 |
| At-risk women | 0.296049 |
|
| African American women | 0.516563 |
| greater risk | 0.249106 |
| experiences headaches | 0.255429 |
| greatest risk | 0.264379 |
| blood pressure increases | 0.454244 |
| gains weight | 0.257496 |
| medical care | 0.507048 |
| prenatal care | 0.686625 |
| birth control | 0.470681 |
| health problems | 0.260374 |
| high blood pressure | 0.932539 |
| pregnancy-related deaths | 0.927048 |
| white women | 0.428892 |
| black women | 0.288828 |
|
CLICK HERE |
| 8933 |
Centers for Disease Control and Prevention |
Html |
en |
Vaccine Information Statement: PCV13 VIS Provider Guidance - Vaccines - CDC |
Provider Guidance for PCV13 VIS |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 8996 |
Centers for Disease Control and Prevention |
Video |
en |
CDC: Tips from Former Smokers -- Brandon's Story |
Brandon describes losing his foot, fingers, and other body parts to Buerger's disease, a disorder linked to smoking, and testifies to the strength of addiction in this video from CDC's "Tips From Former Smokers" campaign.
Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html
This video can also be viewed at
http://streaming.cdc.gov/vod.php?id=f81f096f08347a536dfa06c2779eb30720120516153728421
To learn more about tobacco control and prevention, go to BeTobaccoFree.gov |
| Smokers | 0.932887 |
| CDC | 0.92604 |
|
| Brandon | 0.830424 |
| YouTube | 0.871802 |
|
CLICK HERE |
| 10795 |
Centers for Disease Control and Prevention |
Html |
en |
Preventing Chronic Disease | Developing Theoretically Based and Culturally Appropriate Interventions to Promote Hepatitis B Testing in 4 Asian American Populations, 2006"2011 - CDC |
Hepatitis B infection is 5 to 12 times more common among Asian Americans than in the general US population and is the leading cause of liver disease and liver cancer among Asians. The purpose of this article is to describe the step-by-step approach that we followed in community-based participatory research projects in 4 Asian American groups, conducted from 2006 through 2011 in California and Washington state to develop theoretically based and culturally appropriate interventions to promote hepatitis B testing. We provide examples to illustrate how intervention messages addressing identical theoretical constructs of the Health Behavior Framework were modified to be culturally appropriate for each community. |
| Taylor VM | 0.493171 |
| hepatitis B transmission | 0.487375 |
| hepatitis B virus | 0.594569 |
| hepatitis B booklets | 0.470776 |
| hepatitis B. | 0.549685 |
| self-reported hepatitis | 0.486605 |
| hepatitis b screening | 0.482212 |
| hepatitis b knowledge | 0.522956 |
| hepatitis B blood | 0.553091 |
| intervention development | 0.479528 |
| hepatitis B. Hmong | 0.536597 |
| Hepatitis B Information | 0.476853 |
| guide listing hepatitis | 0.490458 |
| Asian American groups | 0.503112 |
| hepatitis B vaccination | 0.492629 |
| liver disease | 0.498919 |
| hepatitis B infectioncMany | 0.467695 |
| cervical cancer screening | 0.471903 |
| hepatitis B testeThe | 0.466769 |
| community | 0.55447 |
| Asian American populations | 0.490079 |
| cervical cancer | 0.478708 |
| hepatitis B surface | 0.471775 |
| hepatitis B pamphlet | 0.473469 |
| hepatitis BaHepatitis | 0.468942 |
|
| health promotion interventions | 0.508288 |
| Chen MS Jr | 0.475603 |
| intervention | 0.638828 |
| intervention approach | 0.478394 |
| Hepatitis B Internet | 0.47206 |
| cancer screening | 0.521928 |
| print materials | 0.472168 |
| pilot testing | 0.471123 |
| hepatitis b infection | 0.661555 |
| intervention messages | 0.496608 |
| hepatitis B info-cards | 0.471967 |
| Introduction
Hepatitis | 0.512343 |
| health behavior | 0.770886 |
| community-based participatory research | 0.466221 |
| hepatitis B vaccinations | 0.474322 |
| hepatitis B vaccine | 0.468725 |
| hepatitis B infections | 0.487487 |
| hepatitis | 0.92811 |
| lay health workers | 0.692048 |
| chronic hepatitis | 0.594489 |
| hepatitis b testing | 0.920868 |
| et al | 0.681898 |
| high school diploma | 0.515437 |
| liver cancer | 0.607726 |
|
CLICK HERE |
| 12173 |
Centers for Disease Control and Prevention |
Html |
en |
Meningitis | Lab Manual | Biosafety | CDC |
Biosafety Lab Manual for Meningitis Lab Methods. |
| laboratory areas | 0.61735 |
| disposable materials | 0.617695 |
| General laboratory cleanliness | 0.635091 |
| properly equipped laboratory | 0.664048 |
| Laboratory Biosafety Guidelines | 0.678461 |
| Disease Control | 0.616042 |
| S. pneumoniae infections | 0.608601 |
| infectious organisms | 0.618872 |
| infectious agents | 0.764059 |
| Biosafety Level | 0.611807 |
| proper biosafety training | 0.656345 |
| laboratory procedures | 0.617781 |
| Laboratory coats | 0.642678 |
| biosafety cabinet | 0.726815 |
| appropriate biosafety procedures | 0.6699 |
| Waste disposal containers | 0.659094 |
| potentially infectious items | 0.657665 |
| effective general disinfectant | 0.646238 |
| infectious materials | 0.958894 |
| occupationally acquired infections | 0.663689 |
| body fluids | 0.657287 |
| Special disposal containers | 0.604973 |
| laboratory | 0.920776 |
| laboratory-acquired meningococcal infection | 0.603069 |
|
| disinfectant labels | 0.600295 |
| sealable sharps containers | 0.605074 |
| infectious material | 0.824449 |
| household bleach | 0.617767 |
| laboratory worker | 0.610842 |
| Laboratory Standards Institute | 0.687995 |
| laboratory workers | 0.653617 |
| affected area | 0.641003 |
| laboratory work | 0.687175 |
| potentially hazardous procedures | 0.611256 |
| clinical specimens | 0.658463 |
| gloves | 0.633153 |
| hazardous materials | 0.60808 |
| laboratory-acquired H. influenzae | 0.607954 |
| infectious aerosols | 0.613891 |
| ethyl alcohol | 0.643823 |
| laboratory doors | 0.601499 |
| hand washing | 0.623055 |
| infectious waste | 0.618465 |
| protective clothing | 0.643871 |
| splatter guards | 0.601564 |
| laboratory work areas | 0.664828 |
| contaminated materials | 0.599956 |
| laboratory-acquired infections | 0.647657 |
|
CLICK HERE |
| 14405 |
Centers for Disease Control and Prevention |
Html |
en |
Multiple Chronic Conditions and Use of Complementary andAlternative Medicine Among US Adults: Results From the 2012National Health Interview Survey |
Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Chronic Disease Prevention and Health Promotion. PCD provides an open exchange of information and knowledge among researchers, practitioners, policy makers, and others who strive to improve the health of the public through chronic disease prevention. |
| specific CAM modalities | 0.386328 |
| standard chronic condition | 0.369695 |
| standard chronic disease | 0.374485 |
| National Health Interview | 0.378762 |
| multiple chronic conditions | 0.824974 |
| overall CAM | 0.378428 |
| simultaneous chronic conditions | 0.390877 |
| Chronic Conditions Working | 0.424601 |
| practitioner-based CAM | 0.364431 |
| chronic liver disease | 0.384204 |
| different CAM therapies | 0.403509 |
| specific chronic conditions | 0.403265 |
| Conditions Working Group | 0.369951 |
| CAM research | 0.362941 |
| CAM indices | 0.36668 |
| Health Interview Survey | 0.378072 |
| CAM supplement | 0.367733 |
| multiple conditions | 0.36495 |
| CAM therapy | 0.411958 |
| current CAM | 0.370379 |
| CAM variables | 0.369117 |
| chronic disease | 0.392708 |
| chronic bronchitis | 0.366165 |
| chronic disease prevention | 0.390112 |
|
| chronic condition variables | 0.380632 |
| specific CAM therapies | 0.509408 |
| adults | 0.392351 |
| CAM index | 0.400822 |
| chronic comorbid conditions | 0.406122 |
| specific CAM modality | 0.376256 |
| NHIS CAM questionnaire | 0.376919 |
| separate CAM outcomes | 0.374984 |
| severe chronic conditions | 0.387372 |
| CAM therapies | 0.626491 |
| dietary supplements | 0.365146 |
| regular CAM users | 0.369754 |
| Chronic condition management | 0.374003 |
| special diets | 0.371185 |
| dichotomous CAM therapy | 0.382889 |
| herbal therapies | 0.361774 |
| osteopathic manipulation | 0.369521 |
| singular chronic conditions | 0.39006 |
| specific CAM therapy | 0.390944 |
| people | 0.362341 |
| chronic conditions | 0.986272 |
| disease management | 0.419908 |
| chronic disease status | 0.373878 |
| mind–body therapies | 0.393615 |
|
CLICK HERE |